Novavax NVAX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$87.84M-118% | $440.3M+335% | $341.75M+220% | $422.82M+244% | $478.7M+220% | ||
| $22.34M-50.0% | $27.61M-43.1% | $35.01M-25.2% | $41.12M-9.4% | $44.69M+0.8% | ||
| $33.45M-28.6% | $36.02M-25.2% | $38.5M-27.9% | $42M-32.3% | $46.88M-31.3% | ||
| —— | —— | —— | -$630.94M-4,519% | -$189.21M+59.9% | ||
| $5.36M-31.0% | $5.69M-56.4% | $5.54M-72.2% | $4.9M-86.7% | $7.77M-81.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$59.93M+72.4% | -$303.62M-688% | -$319.61M-311% | -$426.58M— | -$217.46M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Novavax generate?
- Novavax (NVAX) generated -$384.9M in operating cash flow over the trailing twelve months.
- What is Novavax's free cash flow?
- After $5.4M of capital expenditures, Novavax's free cash flow was -$389.7M over the trailing twelve months, down 288.4% year over year.
- Where does Novavax's cash flow data come from?
- Every line is extracted from Novavax's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
